Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease

Veerle Bogaerts, Karen Nuytemans, Joke Reumers, Philippe Pals, Sebastiaan Engelborghs, Barbara Pickut, Ellen Corsmit, Karin Peeters, Joost Schymkowitz, Peter Paul De Deyn, Patrick Cras, Frederic Rousseau, Jessie Theuns, Christine Van Broeckhoven

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

In one genetic study, the high temperature requirement A2 (HTRA2) mitochondrial protein has been associated with increased risk for sporadic Parkinson disease (PD). One missense mutation, p.Gly399Ser, in its C-terminal PDZ domain (from the initial letters of the postsynaptic density 95, PSD-95; discs large; and zonula occludens-1, ZO-1 proteins [Kennedy, 1995]) resulted in defective protease activation, and induced mitochondrial dysfunction when overexpressed in stably transfected cells. Here we examined the contribution of genetic variability in HTRA2 to PD risk in an extended series of 266 Belgian PD patients and 273 control individuals. Mutation analysis identified a novel p.Arg404Trp mutation within the PDZ domain predicted to freeze HTRA2 in an inactive form. Moreover, we identified six patient-specific variants in 5′ and 3′ regulatory regions that might affect HTRA2 expression as supported by data of luciferase reporter gene analyses. Our study confirms a role of the HTRA2 mitochondrial protein in PD susceptibility through mutations in its functional PDZ domain. In addition, it extends the HTRA2 mutation spectrum to functional variants possibly affecting transcriptional activity. The latter underpins a previously unrecognized role for altered HTRA2 expression as a risk factor relevant to parkinsonian neurodegeneration.

Original languageEnglish (US)
Pages (from-to)832-840
Number of pages9
JournalHuman Mutation
Volume29
Issue number6
DOIs
StatePublished - Jun 1 2008
Externally publishedYes

Fingerprint

Serine Proteases
varespladib methyl
Parkinson Disease
Temperature
PDZ Domains
Mutation
Mitochondrial Proteins
Post-Synaptic Density
Tight Junctions
Nucleic Acid Regulatory Sequences
Disease Susceptibility
Missense Mutation
Luciferases
Reporter Genes
Peptide Hydrolases
Proteins

Keywords

  • High temperature requirement protein A2
  • HTRA2
  • Mitochondrial serine protease
  • Parkinson disease
  • Regulatory variants

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Bogaerts, V., Nuytemans, K., Reumers, J., Pals, P., Engelborghs, S., Pickut, B., ... Van Broeckhoven, C. (2008). Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease. Human Mutation, 29(6), 832-840. https://doi.org/10.1002/humu.20713

Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease. / Bogaerts, Veerle; Nuytemans, Karen; Reumers, Joke; Pals, Philippe; Engelborghs, Sebastiaan; Pickut, Barbara; Corsmit, Ellen; Peeters, Karin; Schymkowitz, Joost; De Deyn, Peter Paul; Cras, Patrick; Rousseau, Frederic; Theuns, Jessie; Van Broeckhoven, Christine.

In: Human Mutation, Vol. 29, No. 6, 01.06.2008, p. 832-840.

Research output: Contribution to journalArticle

Bogaerts, V, Nuytemans, K, Reumers, J, Pals, P, Engelborghs, S, Pickut, B, Corsmit, E, Peeters, K, Schymkowitz, J, De Deyn, PP, Cras, P, Rousseau, F, Theuns, J & Van Broeckhoven, C 2008, 'Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease', Human Mutation, vol. 29, no. 6, pp. 832-840. https://doi.org/10.1002/humu.20713
Bogaerts, Veerle ; Nuytemans, Karen ; Reumers, Joke ; Pals, Philippe ; Engelborghs, Sebastiaan ; Pickut, Barbara ; Corsmit, Ellen ; Peeters, Karin ; Schymkowitz, Joost ; De Deyn, Peter Paul ; Cras, Patrick ; Rousseau, Frederic ; Theuns, Jessie ; Van Broeckhoven, Christine. / Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease. In: Human Mutation. 2008 ; Vol. 29, No. 6. pp. 832-840.
@article{b26850a540ea4e36a478bffacd74865f,
title = "Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease",
abstract = "In one genetic study, the high temperature requirement A2 (HTRA2) mitochondrial protein has been associated with increased risk for sporadic Parkinson disease (PD). One missense mutation, p.Gly399Ser, in its C-terminal PDZ domain (from the initial letters of the postsynaptic density 95, PSD-95; discs large; and zonula occludens-1, ZO-1 proteins [Kennedy, 1995]) resulted in defective protease activation, and induced mitochondrial dysfunction when overexpressed in stably transfected cells. Here we examined the contribution of genetic variability in HTRA2 to PD risk in an extended series of 266 Belgian PD patients and 273 control individuals. Mutation analysis identified a novel p.Arg404Trp mutation within the PDZ domain predicted to freeze HTRA2 in an inactive form. Moreover, we identified six patient-specific variants in 5′ and 3′ regulatory regions that might affect HTRA2 expression as supported by data of luciferase reporter gene analyses. Our study confirms a role of the HTRA2 mitochondrial protein in PD susceptibility through mutations in its functional PDZ domain. In addition, it extends the HTRA2 mutation spectrum to functional variants possibly affecting transcriptional activity. The latter underpins a previously unrecognized role for altered HTRA2 expression as a risk factor relevant to parkinsonian neurodegeneration.",
keywords = "High temperature requirement protein A2, HTRA2, Mitochondrial serine protease, Parkinson disease, Regulatory variants",
author = "Veerle Bogaerts and Karen Nuytemans and Joke Reumers and Philippe Pals and Sebastiaan Engelborghs and Barbara Pickut and Ellen Corsmit and Karin Peeters and Joost Schymkowitz and {De Deyn}, {Peter Paul} and Patrick Cras and Frederic Rousseau and Jessie Theuns and {Van Broeckhoven}, Christine",
year = "2008",
month = "6",
day = "1",
doi = "10.1002/humu.20713",
language = "English (US)",
volume = "29",
pages = "832--840",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease

AU - Bogaerts, Veerle

AU - Nuytemans, Karen

AU - Reumers, Joke

AU - Pals, Philippe

AU - Engelborghs, Sebastiaan

AU - Pickut, Barbara

AU - Corsmit, Ellen

AU - Peeters, Karin

AU - Schymkowitz, Joost

AU - De Deyn, Peter Paul

AU - Cras, Patrick

AU - Rousseau, Frederic

AU - Theuns, Jessie

AU - Van Broeckhoven, Christine

PY - 2008/6/1

Y1 - 2008/6/1

N2 - In one genetic study, the high temperature requirement A2 (HTRA2) mitochondrial protein has been associated with increased risk for sporadic Parkinson disease (PD). One missense mutation, p.Gly399Ser, in its C-terminal PDZ domain (from the initial letters of the postsynaptic density 95, PSD-95; discs large; and zonula occludens-1, ZO-1 proteins [Kennedy, 1995]) resulted in defective protease activation, and induced mitochondrial dysfunction when overexpressed in stably transfected cells. Here we examined the contribution of genetic variability in HTRA2 to PD risk in an extended series of 266 Belgian PD patients and 273 control individuals. Mutation analysis identified a novel p.Arg404Trp mutation within the PDZ domain predicted to freeze HTRA2 in an inactive form. Moreover, we identified six patient-specific variants in 5′ and 3′ regulatory regions that might affect HTRA2 expression as supported by data of luciferase reporter gene analyses. Our study confirms a role of the HTRA2 mitochondrial protein in PD susceptibility through mutations in its functional PDZ domain. In addition, it extends the HTRA2 mutation spectrum to functional variants possibly affecting transcriptional activity. The latter underpins a previously unrecognized role for altered HTRA2 expression as a risk factor relevant to parkinsonian neurodegeneration.

AB - In one genetic study, the high temperature requirement A2 (HTRA2) mitochondrial protein has been associated with increased risk for sporadic Parkinson disease (PD). One missense mutation, p.Gly399Ser, in its C-terminal PDZ domain (from the initial letters of the postsynaptic density 95, PSD-95; discs large; and zonula occludens-1, ZO-1 proteins [Kennedy, 1995]) resulted in defective protease activation, and induced mitochondrial dysfunction when overexpressed in stably transfected cells. Here we examined the contribution of genetic variability in HTRA2 to PD risk in an extended series of 266 Belgian PD patients and 273 control individuals. Mutation analysis identified a novel p.Arg404Trp mutation within the PDZ domain predicted to freeze HTRA2 in an inactive form. Moreover, we identified six patient-specific variants in 5′ and 3′ regulatory regions that might affect HTRA2 expression as supported by data of luciferase reporter gene analyses. Our study confirms a role of the HTRA2 mitochondrial protein in PD susceptibility through mutations in its functional PDZ domain. In addition, it extends the HTRA2 mutation spectrum to functional variants possibly affecting transcriptional activity. The latter underpins a previously unrecognized role for altered HTRA2 expression as a risk factor relevant to parkinsonian neurodegeneration.

KW - High temperature requirement protein A2

KW - HTRA2

KW - Mitochondrial serine protease

KW - Parkinson disease

KW - Regulatory variants

UR - http://www.scopus.com/inward/record.url?scp=44849115171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44849115171&partnerID=8YFLogxK

U2 - 10.1002/humu.20713

DO - 10.1002/humu.20713

M3 - Article

C2 - 18401856

AN - SCOPUS:44849115171

VL - 29

SP - 832

EP - 840

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 6

ER -